One-Step Surgery With Multipotent Stem Cells for the Treatment of Large Full-Thickness Chondral Defects of the Knee

Abstract

Background:

Chondral lesions in athletically active patients cause considerable morbidity, and treatment with existing cell-based therapies can be challenging. Bone marrow has been shown as a possible source of multipotent stem cells (MSCs) with chondrogenic potential and is easy to harvest during the same surgical procedure.

Purpose:

To investigate the clinical outcome in a group of active patients with large full-thickness chondral defects of the knee treated with 1-step surgery using bone marrow–derived MSCs and a second-generation matrix.

Study Design:

Case series; Level of evidence, 4.

Methods:

From January 2007 to February 2010, 25 patients (average age, 46.5 years) with symptomatic large chondral defects of the knee (International Cartilage Repair Society grade 4) who underwent cartilage transplantation with MSCs and a collagen type I/III matrix were followed up for a minimum of 3 years. The average lesion size was 8.3 cm². Coexisting injuries were treated during the same surgical procedure in 18 patients. All patients underwent a standard postoperative rehabilitation program. Preoperative and postoperative evaluations at 1-year, 2-year, and final follow-up included radiographs, magnetic resonance imaging (MRI), and visual analog scale (VAS) for pain, International Knee Documentation Committee (IKDC), Knee injury and Osteoarthritis Outcome Score (KOOS), Lysholm, Marx, and Tegner scores. Seven patients underwent second-look arthroscopic surgery, with 4 consenting to a tissue biopsy.

Results:

No patients were lost at final follow-up. The average preoperative values for the evaluated scores were significantly improved at final follow-up (P < .001): VAS, 5.4 ± 0.37 to 0.48 ± 0.19; IKDC subjective, 37.92 ± 4.52 to 81.73 ± 2.42; KOOS pain, 61.04 ± 3.95 to 93.32 ± 1.92; KOOS symptoms, 55.64 ± 3.23 to 89.32 ± 2.32; KOOS activities of daily living, 63.96 ± 4.48 to 91.20 ± 2.74; KOOS sports, 34.20 ± 5.04 to 80.00 ± 3.92; KOOS quality of life, 32.20 ± 4.43 to 83.04 ± 3.37; Lysholm, 46.36 ± 2.25 to 86.52 ± 2.73; Marx, 3.00 ± 0.79 to 9.04 ± 0.79; and Tegner, 2.12 ± 0.32 to 5.64 ± 0.26. Patients younger than 45 years of age and those with smaller or single lesions showed better outcomes. The MRI scans showed good stability of the implant and complete filling of the defect in 80% of patients, and hyaline-like cartilage was found in the histological analysis of the biopsied tissue. No adverse reactions or postoperative complications were noted.

Conclusion:

The treatment of large chondral defects with MSCs is an effective procedure and can be performed routinely in clinical practice. Moreover, it can be achieved with 1-step surgery, avoiding a previous surgical procedure to harvest cartilage and subsequent chondrocyte cultivation.

Keywords

cartilage chondral defects MSCs BMAC collagen I/III matrix

Get full access to this article

View all access options for this article.

References

Ando

Tateishi

Katakai

. In vitro generation of a scaffold-free tissue-engineered construct (TEC) derived from human synovial mesenchymal stem cells: biological and mechanical properties and further chondrogenic potential. Tissue Eng Part A. 2008;14(12):2041-2049.

Anitua

Sanchez

Orive

Andia

. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials. 2007;28(31):4551-4560.

Behrens

Bitter

Kurz

Russlies

. Matrix-associated autologous chondrocyte transplantation/implantation (MACT/MACI): 5-year follow-up. Knee. 2006;13(3):194-202.

Brittberg

Lindahl

Nilsson

. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14):889-895.

Caplan

. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005;11(7-8):1198-1211.

Caplan

. Mesenchymal stem cells: the past, the present, the future. Cartilage. 2010;1(1):6-9.

Cavallo

Desando

Cattini

. Bone marrow concentrated cell transplantation: rationale for its use in the treatment of human osteochondral lesions. J Biol Regul Homeost Agents. 2013;27(1):165-175.

Chambers

Goodell

. Hematopoietic stem cell aging: wrinkles in stem cell potential. Stem Cell Rev. 2007;3(3):201-211.

Coelho

Cabral

Karp

. Intraoperative stem cell therapy. Annu Rev Biomed Eng. 2012;14:325-349.

10.

Dominici

Le Blanc

Mueller

. Minimal criteria for deﬁning multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006;8(4):315-317.

11.

Fortier

Potter

Rickey

. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am. 2010;92(10):1927-1937.

12.

Gobbi

Karnatzikos

Kumar

. Long-term results after microfracture treatment for full-thickness knee chondral lesions in athletes [published online September 20, 2013]. Knee Surg Sports Traumatol Arthrosc. doi:10.1007/s00167-013-2676-8.

13.

Gobbi

Karnatzikos

Nakamura

Mahajan

. Next generation cartilage solutions. In: Doral

, ed. Sports Injuries: Prevention, Diagnosis, Treatment and Rehabilitation. Berlin: Springer Verlag; 2012:739-749.

14.

Gobbi

Karnatzikos

Scotti

. One-step cartilage repair with bone marrow aspirate concentrated cells and collagen matrix in full-thickness knee cartilage lesions: results at 2 year follow up. Cartilage. 2011;2(3):286-299.

15.

Gobbi

Kon

Berruto

. Patellofemoral full-thickness chondral defects treated with second-generation autologous chondrocyte implantation: results at 5 years’ follow-up. Am J Sports Med. 2009;37(6):1083-1092.

16.

Grigolo

Lisignoli

Desando

. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods. 2009;15(4):647-658.

17.

Harris

McNeilan

Siston

Flanigan

. Survival and clinical outcome of isolated high tibial osteotomy and combined biological knee reconstruction. Knee. 2013;20(3):154-161.

18.

Hermann

Huber

Herrler

. Concentration of bone marrow total nucleated cells by a point-of-care device provides a high yield and preserves their functional activity. Cell Transplant. 2008;16(10):1059-1069.

19.

Horas

Pelinkovic

Herr

Aigner

. Autologous chondrocyte implantation and osteochondral cylinder transplantation in cartilage repair of the knee joint: a prospective, comparative trial. J Bone Joint Surg Am. 2003;85(2):185-192.

20.

Horwitz

Dominici

. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7(5):393-395.

21.

Hui

Chen

Thambyah

Lee

. Treatment of chondral lesions in advanced osteochondritis dissecans: a comparative study of the efficacy of chondrocytes, mesenchymal stem cells, periosteal graft, and mosaicplasty (osteochondral autograft) in animal models. J Pediatr Orthop. 2004;24(4):427-433.

22.

Irrgang

Anderson

Boland

. Development and validation of the International Knee Documentation Committee subjective knee form. Am J Sports Med. 2001;29(5):600-613.

23.

Jones

McGonagle

. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford). 2008;47(2):126-131.

24.

Knutsen

Engebretsen

Ludvigsen

. Autologous chondrocyte implantation compared with microfracture in the knee: a randomized trial. J Bone Joint Surg Am. 2004;86(3):455-464.

25.

Kobayashi

Ochi

Yanada

. A novel cell delivery system using magnetically labelled mesenchymal stem cells and an external magnetic device for clinical cartilage repair. Arthroscopy. 2008;24(1):69-76.

26.

Kon

Gobbi

Filardo

. Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: prospective nonrandomized study at 5 years. Am J Sports Med. 2009;37(1):33-41.

27.

Kotlarz

Gunnarsson

Fang

Rizzo

. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60(12):3546-3553.

28.

Kramer

Kocher

. Management of patellar and trochlear chondral injuries. Oper Tech Orthop. 2007;17(4):234-243.

29.

Lysholm

Gillquist

. Evaluation of knee ligament surgery results with special emphasis on use of a scoring scale. Am J Sports Med. 1982;10(3):150-154.

30.

Mandelbaum

Browne

. Treatment outcomes of autologous chondrocyte implantation for full-thickness articular cartilage defects of the trochlea. Am J Sports Med. 2007;35(6):915-921.

31.

Mankin

. The response of articular cartilage to mechanical injury. J Bone Joint Surg Am. 1982;64(3):460-466.

32.

Marcacci

Berruto

Brocchetta

. Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res. 2005;435:96-105.

33.

Marx

Stump

Jones

Wickiewicz

Warren

. Development and evaluation of an activity rating scale for disorders of the knee. Am J Sports Med. 2001;29(2):213-218.

34.

Minas

Peterson

. Advanced techniques in autologous chondrocyte transplantation. Clin Sports Med. 1999;18(1):13-44, v-vi.

35.

Minzlaff

Feucht

Saier

. Osteochondral autologous transfer combined with valgus high tibial osteotomy: long-term results and survivorship analysis. Am J Sports Med. 2013;41(10):2325-2332.

36.

Nakamura

Sekiya

Muneta

. Arthroscopic, histological and MRI analyses of cartilage repair after a minimally invasive method of transplantation of allogeneic synovial mesenchymal stromal cells into cartilage defects in pigs. Cytotherapy. 2012;14(3):327-338.

37.

Nejadnik

Hui

Feng Choong

. Autologous bone marrow–derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110-1116.

38.

Ochi

Adachi

Nobuto

. Articular cartilage repair using tissue engineering technique: novel approach with minimally invasive procedure. Artif Organs. 2004;28(1):28-32.

39.

Oreffo

Bennett

Carr

Triffitt

. Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. Scand J Rheumatol. 1998;27(6):415-424.

40.

Pelttari

Steck

Richter

. The use of mesenchymal stem cells for chondrogenesis. Injury. 2008;39 Suppl 1:S58-S65.

41.

Peterson

Vasiliadis

Brittberg

Lindahl

. Autologous chondrocyte implantation: a long-term follow-up. Am J Sports Med. 2010;38(6):1117-1124.

42.

Potter

Linklater

Allen

Hannafin

Haas

. Magnetic resonance imaging of articular cartilage in the knee: an evaluation with use of fast-spin-echo imaging. J Bone Joint Surg Am. 1998;80(9):1276-1284.

43.

Quarto

Thomas

Liang

. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Calcif Tissue Int. 1995;56(2):123-129.

44.

Robey

Bianco

. The use of adult stem cells in rebuilding the human face. J Am Dent Assoc. 2006;137(7):961-972.

45.

Roobrouck

Ulloa-Montoya

Verfaillie

. Self-renewal and differentiation capacity of young and aged stem cells. Exp Cell Res. 2008;314(9):1937-1944.

46.

Roos

Lohmander

Ekdahl

Beynnon

. Knee Injury and Osteoarthritis Outcome Score (KOOS): development of a self-administered outcome measure. J Orthop Sports Phys Ther. 1998;28(2):88-96.

47.

Salzmann

Niemeyer

Steinwachs

. Cartilage repair approach and treatment characteristics across the knee joint: a European survey. Arch Orthop Trauma Surg. 2011;131(3):283-291.

48.

Scotti

Tonnarelli

Papadimitropoulos

. Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering. Proc Natl Acad Sci U S A. 2010;107(16):7251-7256.

49.

Scotti

Wirz

Wolf

. Engineering human cell-based, functionally integrated osteochondral grafts by biological bonding of engineered cartilage tissues to bony scaffolds. Biomaterials. 2010;31(8):2252-2259.

50.

Sgaglione

Miniaci

Gillogly

Carter

. Update on advanced surgical techniques in the treatment of traumatic focal articular cartilage lesions in the knee. Arthroscopy. 2002;18(2 Suppl 1):9-32.

51.

Takeda

Nakagawa

Nakamura

Engebretsen

. Prevention and management of knee osteoarthritis and knee cartilage injury in sports. Br J Sports Med. 2011;45(4):304-309.

52.

Tateishi

Ando

Higuchi

. Comparison of human serum with fetal bovine serum for expansion and differentiation of human synovial MSC: potential feasibility for clinical applications. Cell Transplant. 2008;17(5):549-557.

53.

Tegner

Lysholm

. Rating systems in the evaluation of knee ligament injuries. Clin Orthop Relat Res. 1985;198:43-49.

54.

Wakitani

Imoto

Yamamoto

. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthritis Cartilage. 2002;10(3):199-206.

55.

Widuchowski

Trzaska

. Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007;14(3):177-182.

56.

Wilke

Nydam

Nixon

. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res. 2007;25(7):913-925.

57.

Wright

. Knee injury outcomes measures. J Am Acad Orthop Surg. 2009;17(1):31-39.

58.

Yanada

Ochi

Adachi

. Effects of CD44 antibody—or RGDS peptide—immobilized magnetic beads on cell proliferation and chondrogenesis of mesenchymal stem cells. J Biomed Mater Res A. 2006;77(4):773-784.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.86 MB